TABLE 3

Baseline and 4-year follow-up data and 4-year changes in anthropometric and metabolic values in participants who participated in repeated FSIGT examination

Intervention group
Control group
Baseline*4-yearChangenPBaseline4-yearChangenP
Age (years) 56 ± 7     55 ± 7     
Weight (kg) 84.6 ± 13.9 79.6 ± 15.8 −4.9 ± 4.9§ 31 <0.001 84.9 ± 14.2 83.5 ± 14.3 −1.4 ± 5.5 21 <0.001 
BMI (kg/m230.4 ± 3.9 28.6 ± 4.4 −1.8 ± 1.9 31 <0.001 30.5 ± 4.1 30.0 ± 3.9 −0.5 ± 2.0 21 0.227 
Waist circumference (cm) 102.3 ± 11.0 98.1 ± 12.2 −4.2 ± 5.2§ 31 <0.001 102.0 ± 8.3 99.9 ± 7.8 −1.8 ± 4.5 20 0.096 
Fasting glucose (mmol/l) 6.2 ± 0.8 6.3 ± 0.8 0.08 ± 0.73 31 0.557 6.2 ± 0.6 6.3 ± 0.7 0.10 ± 0.75 21 0.537 
2-h glucose (mmol/l) 8.8 ± 1.6 9.2 ± 2.8 0.39 ± 3.09 31 0.544 8.6 ± 1.5 8.9 ± 1.5 0.23 ± 2.38 21 0.659 
Fasting insulin (pmol/l) 78.0 ± 36.3 68.9 ± 38.7 −15.4 ± 27.0 29 0.001 103.1 ± 57.6 77.7 ± 29.3 −25.7 ± 60.3 20 0.086 
2-h insulin (pmol/l) 577 ± 405 441 ± 290 −168 ± 417 19 0.152 556 ± 332 510 ± 276 −68 ± 378 15 0.344 
HbA1c (%) 5.9 ± 0.9 5.8 ± 0.5 −0.11 ± 0.99 30 0.559 5.8 ± 0.9 5.9 ± 0.5 0.14 ± 0.95 20 0.531 
AIR (mU · l−1 · min−1272 ± 299 244 ± 245 −27 ± 162 31 0.281 336 ± 284 270 ± 210 −66 ± 107 21 0.011 
Si (×10−4 · min−1 · μU−1 · ml−12.13 ± 1.37 2.64 ± 1.44 0.34 ± 1.46 28 0.227 1.91 ± 1.12 1.94 ± 0.95 0.16 ± 0.96 20 0.474 
Sg ([min]−1 · 1021.50 ± 0.54 1.54 ± 0.50 0.05 ± 0.69 29 0.683 1.66 ± 0.46 1.34 ± 0.43 −0.32 ± 0.63 20 0.036 
Intervention group
Control group
Baseline*4-yearChangenPBaseline4-yearChangenP
Age (years) 56 ± 7     55 ± 7     
Weight (kg) 84.6 ± 13.9 79.6 ± 15.8 −4.9 ± 4.9§ 31 <0.001 84.9 ± 14.2 83.5 ± 14.3 −1.4 ± 5.5 21 <0.001 
BMI (kg/m230.4 ± 3.9 28.6 ± 4.4 −1.8 ± 1.9 31 <0.001 30.5 ± 4.1 30.0 ± 3.9 −0.5 ± 2.0 21 0.227 
Waist circumference (cm) 102.3 ± 11.0 98.1 ± 12.2 −4.2 ± 5.2§ 31 <0.001 102.0 ± 8.3 99.9 ± 7.8 −1.8 ± 4.5 20 0.096 
Fasting glucose (mmol/l) 6.2 ± 0.8 6.3 ± 0.8 0.08 ± 0.73 31 0.557 6.2 ± 0.6 6.3 ± 0.7 0.10 ± 0.75 21 0.537 
2-h glucose (mmol/l) 8.8 ± 1.6 9.2 ± 2.8 0.39 ± 3.09 31 0.544 8.6 ± 1.5 8.9 ± 1.5 0.23 ± 2.38 21 0.659 
Fasting insulin (pmol/l) 78.0 ± 36.3 68.9 ± 38.7 −15.4 ± 27.0 29 0.001 103.1 ± 57.6 77.7 ± 29.3 −25.7 ± 60.3 20 0.086 
2-h insulin (pmol/l) 577 ± 405 441 ± 290 −168 ± 417 19 0.152 556 ± 332 510 ± 276 −68 ± 378 15 0.344 
HbA1c (%) 5.9 ± 0.9 5.8 ± 0.5 −0.11 ± 0.99 30 0.559 5.8 ± 0.9 5.9 ± 0.5 0.14 ± 0.95 20 0.531 
AIR (mU · l−1 · min−1272 ± 299 244 ± 245 −27 ± 162 31 0.281 336 ± 284 270 ± 210 −66 ± 107 21 0.011 
Si (×10−4 · min−1 · μU−1 · ml−12.13 ± 1.37 2.64 ± 1.44 0.34 ± 1.46 28 0.227 1.91 ± 1.12 1.94 ± 0.95 0.16 ± 0.96 20 0.474 
Sg ([min]−1 · 1021.50 ± 0.54 1.54 ± 0.50 0.05 ± 0.69 29 0.683 1.66 ± 0.46 1.34 ± 0.43 −0.32 ± 0.63 20 0.036 

Data are mean ± SD.

*

There were no significant differences in any of the baseline variables between the intervention and control groups.

P value within the study group change.

P < 0.05 between the study groups.

§

P = 0.043 for the change in weight and P = 0.025 for the change in waist circumference, adjusted for age and sex, between the study groups when all participants with follow-up data are included (n = 39 for intervention and n = 29 for control group).

Close Modal

or Create an Account

Close Modal
Close Modal